The Canadian Cancer Society Breakthrough Team Grants will soon be open for applications

The Canadian Cancer Society shared on LinkedIn:

“NEW FUNDING OPPORTUNITY: We’re excited to announce that the Canadian Cancer Society Breakthrough Team Grants will soon be open for applications from cross-disciplinary teams seeking to address research gaps and improve outcomes for people affected by metastatic cancer.

These grants seek to bring together scientists, clinicians, patient partners and knowledge users from across disciplines to collaborate on ambitious projects.

We anticipate funding at least 1 team in each of the 2 themes of the program: 1) to develop a better understanding of the biology of and mechanisms associated with cancer cell dormancy and 2) to enhance support for people living with advanced or metastatic disease. Successful teams will receive a maximum of $1.5 million per year for 5 years, for a total investment of $15 million.

Important dates:

•  Program launch – April 2024
•  Networking workshops (mandatory registration for PIs) – May 9 (12-3 pm ET)
•  Letter of Intent (LOI) submission (mandatory) – June 27, 2024
•  Full applications due – October 15, 2024
•  Funding starts – January 15, 2025

For more information, visit this link.”

Source: Canadian Cancer Society/LinkedIn

About OncoDaily 

OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.

OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.

The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we“.